Comparison 23. Mizoribine ± steroids versus placebo/no treatment/corticosteroids.

Outcome or subgroup title	No. of studies	No. of participants	Statistical method	Effect size
23.1 Complete or partial remission	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
23.1.1 Complete or partial remission at final follow‐up	2	114	Risk Ratio (M‐H, Random, 95% CI)	2.24 [1.14, 4.38]
23.1.2 Complete or partial remission at final follow‐up (≥ 2 years)	1	25	Risk Ratio (M‐H, Random, 95% CI)	4.71 [0.66, 33.61]
23.2 Complete remission	3		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
23.2.1 Complete remission at final follow‐up	3	150	Risk Ratio (M‐H, Random, 95% CI)	1.63 [0.69, 3.84]
23.2.2 Complete remission at final follow‐up (> 2 years)	1	25	Risk Ratio (M‐H, Random, 95% CI)	5.60 [0.32, 98.21]
23.3 Partial remission	2		Risk Ratio (M‐H, Random, 95% CI)	Subtotals only
23.3.1 Partial remission at final follow‐up	2	114	Risk Ratio (M‐H, Random, 95% CI)	1.89 [0.90, 3.97]
23.3.2 Partial remission at final follow‐up (≥ 2 years)	1	25	Risk Ratio (M‐H, Random, 95% CI)	2.36 [0.28, 19.66]
23.4 Temporary or permanent discontinuation/hospitalisation due to adverse events	1	89	Risk Ratio (M‐H, Random, 95% CI)	4.29 [0.21, 86.80]